Specifically, we compared FANCD2 genome binding in our three datasets to existing MiDAS datasets for two cancer-derived cell lines (HeLa and U2OS) and one non-cancer-derived line (HS68) (Macheret et al. 2020). Here, FANCD2 is linked to cancer.